BlackRock Capital Allocation Term Trust (NYSE:BCAT) Sets New 1-Year Low – Time to Sell?

Posted by Geri Gentry on Sep 24th, 2026

BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report) reached a new 52-week low during trading on Thursday . The stock traded as low as $13.64 and last traded at $13.6450, with a volume of 603057 shares traded. The stock had previously closed at $13.95.

BlackRock Capital Allocation Term Trust Stock Down 1.7%

The company’s 50 day simple moving average is $15.54 and its two-hundred day simple moving average is $15.36.

BlackRock Capital Allocation Term Trust Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, December 22nd. Stockholders of record on Friday, December 11th will be issued a dividend of $0.2501 per share. The ex-dividend date is Friday, December 11th. This represents a c) annualized dividend and a dividend yield of 21.9%.

Institutional Trading of BlackRock Capital Allocation Term Trust

A number of institutional investors have recently bought and sold shares of BCAT. McIlrath & Eck LLC increased its stake in BlackRock Capital Allocation Term Trust by 169.6% during the 1st quarter. McIlrath & Eck LLC now owns 3,130 shares of the company’s stock valued at $44,000 after purchasing an additional 1,969 shares in the last quarter. Global Retirement Partners LLC purchased a new stake in shares of BlackRock Capital Allocation Term Trust during the second quarter valued at $115,000. Fifth Third Bancorp acquired a new position in shares of BlackRock Capital Allocation Term Trust in the 1st quarter valued at $137,000. BlackRock Inc. acquired a new position in shares of BlackRock Capital Allocation Term Trust in the 2nd quarter valued at $152,000. Finally, Sovran Advisors LLC purchased a new position in BlackRock Capital Allocation Term Trust in the 1st quarter worth $201,000. 36.12% of the stock is currently owned by institutional investors and hedge funds.

About BlackRock Capital Allocation Term Trust

(Get Free Report)

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a diversified, closed-end management investment company advised by BlackRock Advisors, LLC. The fund seeks to provide total return through a combination of current income and capital appreciation.

BCAT invests across both equity and debt markets. Its portfolio may include common stocks, preferred securities, convertible securities, investment-grade and below-investment-grade corporate bonds, loans, and other fixed-income instruments.